ALLEVIATE-1: A Study of Cebranopadol for the Treatment of Acute Pain After Abdominoplasty (clinicaltrials.gov) - Jan 9, 2026 - P3 | N=279 | Completed | Sponsor: Tris Pharma, Inc. | Active, not recruiting ➔ Completed
Trial completion • Aesthetic Medicine • Pain
|